{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003966",
      "entity_text" : "thrombin",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06224",
      "entity_text" : "antithrombin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR Since the capacity of antithrombin to inhibit thrombin is known to increase dramatically in the presence of heparin, beta-antithrombin is considered to be the major antithrombogenic contributor in plasma, even though it is present in much smaller amounts than other contributors.",
  "reading_complete" : "2020-08-03T17:38:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:37:13Z",
  "trigger" : "inhibit",
  "evidence" : [ "antithrombin to inhibit thrombin" ],
  "pmc_id" : "6524836",
  "score" : 0
}